JPH04273815A - 局所適用用組成物 - Google Patents

局所適用用組成物

Info

Publication number
JPH04273815A
JPH04273815A JP3266468A JP26646891A JPH04273815A JP H04273815 A JPH04273815 A JP H04273815A JP 3266468 A JP3266468 A JP 3266468A JP 26646891 A JP26646891 A JP 26646891A JP H04273815 A JPH04273815 A JP H04273815A
Authority
JP
Japan
Prior art keywords
liposomes
composition
binding
microcapsules
beneficial substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3266468A
Other languages
English (en)
Japanese (ja)
Inventor
Sheila Elizabeth Francis
シーラ・エリザベス・フランシス
Fiona Jane Hutchinson
フイオウナ・ジエイン・ハツチンスン
Noaclife Johns Malcolm
マルカム・ノアクリフエ・ジヨンズ
Ian Gardner Lyle
イーアン・ガードナ・ライル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever NV
Original Assignee
Unilever NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909022298A external-priority patent/GB9022298D0/en
Application filed by Unilever NV filed Critical Unilever NV
Publication of JPH04273815A publication Critical patent/JPH04273815A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6911Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Glass Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP3266468A 1990-10-15 1991-10-15 局所適用用組成物 Pending JPH04273815A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9022298.5 1990-10-15
GB909022298A GB9022298D0 (en) 1990-10-15 1990-10-15 Treatment composition
IN305BO1991 IN173187B (2) 1990-10-15 1991-10-14

Publications (1)

Publication Number Publication Date
JPH04273815A true JPH04273815A (ja) 1992-09-30

Family

ID=26297800

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3266468A Pending JPH04273815A (ja) 1990-10-15 1991-10-15 局所適用用組成物

Country Status (6)

Country Link
EP (1) EP0481701B1 (2)
JP (1) JPH04273815A (2)
AT (1) ATE128622T1 (2)
AU (1) AU652778B2 (2)
IN (1) IN173187B (2)
ZA (1) ZA918211B (2)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003509438A (ja) * 1999-09-16 2003-03-11 ユニリーバー・ナームローゼ・ベンノートシヤープ 抗フケ剤の送達システム
JP2015083562A (ja) * 2013-09-18 2015-04-30 第一三共ヘルスケア株式会社 特定の平均粒径を有する薬物担体を含有する口腔用組成物
JP2015124154A (ja) * 2013-12-25 2015-07-06 サンスター株式会社 口腔又は咽喉用組成物
JP2015174860A (ja) * 2014-03-18 2015-10-05 サンスター株式会社 オーラルケア組成物
JP2018115179A (ja) * 2018-03-16 2018-07-26 サンスター株式会社 オーラルケア組成物

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL296382A1 (en) * 1991-02-02 1993-11-02 Nika Health Products Ltd Li Li Artificial membrane beads containing functionally active peptides responsible for fusion as a drug administering system
AU651414B2 (en) * 1991-02-14 1994-07-21 Baxter International Inc. Binding of recognizing substances to liposomes
US5603872A (en) * 1991-02-14 1997-02-18 Baxter International Inc. Method of binding recognizing substances to liposomes
AU656173B2 (en) * 1991-02-14 1995-01-27 Baxter International Inc. Interaction between bioadhesive liposomes and target sites
FR2676362B3 (fr) * 1991-05-17 1993-08-13 Oreal Procede pour accroitre l'activite d'au moins un actif dans une composition a usage cosmetique et/ou dermopharmaceutique et composition pour la mise en óoeuvre dudit procede.
GB9208339D0 (en) * 1992-04-15 1992-06-03 Unilever Plc Treatment composition
JPH092926A (ja) * 1995-04-12 1997-01-07 Quest Internatl Bv 口内組成物
EP0737470A1 (en) * 1995-04-12 1996-10-16 Quest International B.V. Oral care compositions
KR19980075132A (ko) * 1997-03-28 1998-11-05 민병무 중간사슬지방산(medium-chain fatty acids)을 유효성분으로 하는 치아우식증 및 치주질환 치료제용 의약조성물
DE19745950A1 (de) * 1997-10-17 1999-04-22 Dds Drug Delivery Service Ges Arzneistoffträgerpartikel für die gewebespezifische Arzneistoffapplikation
US5972311A (en) * 1998-01-26 1999-10-26 Duke University Method of preventing dental caries and other oral lesions
IN190017B (2) * 1999-01-25 2003-05-31 Panacea Biotech Ltd
US6861077B1 (en) 2000-03-17 2005-03-01 L'oreal S.A. Use of plant extracts in a cosmetic composition to protect keratinous fibers
US6416745B1 (en) * 2001-05-03 2002-07-09 Block Drug Company, Inc. Dental composition for treating hypersensitive teeth
FR3071729B1 (fr) * 2017-10-04 2026-01-16 Cementic Ciments dentaires desinfectants comprenant des liposomes
WO2021064608A1 (en) * 2019-09-30 2021-04-08 Centitvc - Centro De Nanotecnologia E Materiais Técnicos Funcionais E Inteligentes Capsule for functionalizing a product, method and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3911099A (en) * 1974-01-23 1975-10-07 Defoney Brenman Mayes & Baron Long-acting articles for oral delivery and process
CA1165238A (en) * 1980-03-12 1984-04-10 Demetrios P. Papahadjopoulos Activated liposomes and method
US4470967A (en) * 1982-10-05 1984-09-11 Iowa State University Research Foundation Lectin-containing anti-viral vaccines for domestic animals and method of preparation
US4767615A (en) * 1984-05-03 1988-08-30 Technology Unlimited, Inc. Dental therapy by vesicle delivery
WO1986004232A1 (en) * 1985-01-18 1986-07-31 Cooper-Lipotech, Inc. Liposome composition and method
US4762915A (en) * 1985-01-18 1988-08-09 Liposome Technology, Inc. Protein-liposome conjugates
DE3542773A1 (de) * 1985-12-04 1987-06-11 Roehm Pharma Gmbh Hautwirksame pharmaka mit liposomen als wirkstofftraeger
US5000960A (en) * 1987-03-13 1991-03-19 Micro-Pak, Inc. Protein coupling to lipid vesicles
EP0462145B1 (en) * 1989-03-07 1994-04-27 Genentech, Inc. Covalent conjugates of lipid and oligonucleotide

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003509438A (ja) * 1999-09-16 2003-03-11 ユニリーバー・ナームローゼ・ベンノートシヤープ 抗フケ剤の送達システム
JP2015083562A (ja) * 2013-09-18 2015-04-30 第一三共ヘルスケア株式会社 特定の平均粒径を有する薬物担体を含有する口腔用組成物
JP2015124154A (ja) * 2013-12-25 2015-07-06 サンスター株式会社 口腔又は咽喉用組成物
JP2015174860A (ja) * 2014-03-18 2015-10-05 サンスター株式会社 オーラルケア組成物
JP2018115179A (ja) * 2018-03-16 2018-07-26 サンスター株式会社 オーラルケア組成物

Also Published As

Publication number Publication date
ZA918211B (en) 1993-04-15
EP0481701A1 (en) 1992-04-22
EP0481701B1 (en) 1995-10-04
AU652778B2 (en) 1994-09-08
AU8574291A (en) 1992-04-16
IN173187B (2) 1994-02-26
ATE128622T1 (de) 1995-10-15

Similar Documents

Publication Publication Date Title
JPH04273815A (ja) 局所適用用組成物
AU674842B2 (en) Cosmetic composition
CA1339008C (en) Amphotericin b liposome preparation
Maestrelli et al. New “drug-in cyclodextrin-in deformable liposomes” formulations to improve the therapeutic efficacy of local anaesthetics
JPH0761947B2 (ja) リン脂質ミセル粒子に被包されたアントラサイクリン抗腫瘍薬
Yi et al. Farnesal-loaded pH-sensitive polymeric micelles provided effective prevention and treatment on dental caries
Jones et al. The targeting of phospholipid liposomes to bacteria
JP2022126810A (ja) 単層リポソームにおける親水性化合物の高い効率の封入
Robinson et al. The use of immunoliposomes for specific delivery of antimicrobial agents to oral bacteria immobilized on polystyrene
Dhanyalayam et al. Biopolymeric self-assembled nanoparticles for enhanced antibacterial activity of Ag-based compounds
Mutreja et al. Lipid nanoparticle-based formulations for high-performance dentistry applications
JP6580735B2 (ja) オーラルケア組成物
Shaji et al. Novel double loaded transferosomes: evidence of superior anti-inflammatory efficacy-a comparative study
Jones et al. The use of phospholipid liposomes for targeting to oral and skin-associated bacteria
JP5212954B2 (ja) カーボンナノホーンの分散方法
JPH05506253A (ja) 生体接着性リポソームの外用による持続的薬物放出
CA2053346C (en) Microcapsule compositions for torical treatment
JP2007091686A (ja) ヒノキチオールを含有するナノ粒子
JP2002535266A (ja) 細胞保護およびH.pylori感染の処置のための標的化小胞構築物
Chandraprakash et al. Effect of macrophage activation on plasma disposition of niosomal 3H-Methotrexate in sarcoma-180 bearing mice
EP0429442B1 (en) Dental therapy by vesicle delivery
Rehse et al. Platelet Aggregation Inhibiting and Anticoagulant Effects of Oligoamines, XXIV: Interactions between Oligosydnone Imines and Albumine or Phospholipids
RU2788456C2 (ru) Высокоэффективная инкапсуляция гидрофильных соединений в униламеллярные липосомы
Catuogno The interaction of liposomes with zinc citrate particles for drug delivery on oral bacteria Streptococcus oralis
JP2000302685A (ja) 抗腫瘍薬含有リポソーム製剤